WebNov 1, 2024 · This review describes some of the most promising novel biomarkers of AKI, including neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule 1 (KIM-1), interleukin 18 (lL-18), liver-type fatty-acid-binding protein (L-FABP), insulin-like-growth-factor-binding protein 7 (IGFBP7), and tissue inhibitor of metalloproteinase 2 (TIMP-2). WebOct 10, 2024 · Although many studies have shown NGAL to be a novel biomarker of early and sensitive AKI detection, its potential usefulness in decompensated cirrhosis remains …
Acute Kidney Injury in Patients with Cirrhosis NEJM
WebFeb 8, 2014 · Because numerous other novel candidate AKI biomarkers are similarly in various stages of development and validation, there appears to be a glimmer of hope in … WebOct 29, 2024 · Cystatin C and urinary neutrophil gelatinase‐associated lipocalin (NGAL) are the most studied candidate biomarkers and identify AKI or progression of AKI earlier than serum creatinine (sCr).... jeans bound
Serum Neutrophil Gelatinase-Associated Lipocalin – A …
WebAcute kidney injury (AKI) is one of the most common and morbid complications of decompensated cirrhosis. Management of AKI is dictated by cause: prerenal AKI is treated with volume resuscitation; hepatorenal syndrome (HRS), with intravenous albumin and vasoconstrictors; WebCystatin C and urinary neutrophil gelatinase‐associated lipocalin (uNGAL) are the most studied candidate biomarkers and identify AKI or progression of AKI earlier than serum creatinine (sCr). Kidney injury molecule 1 and liver‐type fatty acid–binding protein (L‐FABP) also show potential. WebThis review details the physiology predisposing cirrhotic patients to AKI, assesses the prevalence and outcomes of different causes of AKI, presents the limitations in our current framework of diagnosis and prognosis and explores a new framework for understanding AKI in cirrhosis incorporating novel biomarkers of kidney injury. o with colon on top